文献速递精神分裂症与精神病性障碍

从群体到个体:精神分裂症谱系障碍社会认知损伤的生物标志物与治疗转化

From the Group to the Individual in Schizophrenia Spectrum Disorders: Biomarkers of Social Cognitive Impairments and Therapeutic Translation.
PubMed 文献 · Biol Psychiatry · 2021-09-20

精神分裂症谱系障碍患者常存在持续的社会认知损伤,与功能结局不良相关,目前尚无获批的治疗方案。本文综述了将功能连接生物标志物发现转化为个体化治疗的发展路线图,包括机器学习维度脑-行为生物标志物发现、重复经颅磁刺激等脑刺激技术靶向相关网络以及基于功能连接的个体化靶向,并指出该转化路线图正在精准引导试验中评估。

要点

  • 精神分裂症谱系障碍的社会认知损伤持续存在且与功能结局不良相关,目前无获批治疗。
  • 机器学习可用于维度脑-行为生物标志物发现,强调个体差异的重要性。
  • 基于功能连接的个体化靶向可能增强脑刺激治疗反应,该路线图正在精准引导试验中评估。

核心结论

  • 综合文献支持这种转化方法用于精准治疗的效用和可行性。
  • 所提出的将社会认知损伤生物标志物转化为个体化治疗的路线图目前正在精准引导试验中评估。
  • 这种转化方法也可能适用于其他疾病,并可推广用于开发针对其他行为缺陷的个体化神经刺激靶向。

研究设计与样本

  • 本文为综述,综述了支持将功能连接生物标志物发现转化为精神分裂症谱系障碍社会认知损伤个体化治疗开发路线图的文献。

主要发现

  • 精神分裂症谱系障碍患者常经历持续的社会认知损伤,与功能结局不良相关。
  • 迄今为止的工作阐明了精神分裂症谱系障碍中受影响的不同社会过程和潜在神经环路,这些可能适合使用神经刺激进行调制。
  • 功能连接映射和电场建模的进展可用于识别个体化治疗靶点,以最大化脑刺激对社会认知网络的影响。
  • 机器学习方法用于维度脑-行为生物标志物发现,强调个体差异的重要性。
  • 脑刺激技术如重复经颅磁刺激可用于靶向相关网络,基于功能连接的个体化靶向可能增强治疗反应。

关键数值与推荐

  • 目前尚无获批的治疗方案用于精神分裂症谱系障碍的社会认知损伤。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

People with schizophrenia spectrum disorders (SSDs) often experience persistent social cognitive impairments, associated with poor functional outcome. There are currently no approved treatment options for these debilitating symptoms, highlighting the need for novel therapeutic strategies. Work to date has elucidated differential social processes and underlying neural circuitry affected in SSDs, which may be amenable to modulation using neurostimulation. Further, advances in functional connectivity mapping and electric field modeling may be used to identify individualized treatment targets to maximize the impact of brain stimulation on social cognitive networks. Here, we review literature supporting a roadmap for translating functional connectivity biomarker discovery to individualized treatment development for social cognitive impairments in SSDs. First, we outline the relevance of social cognitive impairments in SSDs. We review machine learning approaches for dimensional brain-behavior biomarker discovery, emphasizing the importance of individual differences. We synthesize research showing that brain stimulation techniques, such as repetitive transcranial magnetic stimulation, can be used to target relevant networks. Further, functional connectivity-based individualized targeting may enhance treatment response. We then outline recent approaches to account for neuroanatomical variability and optimize coil positioning to individually maximize target engagement. Overall, the synthesized literature provides support for the utility and feasibility of this translational approach to precision treatment. The proposed roadmap to translate biomarkers of social cognitive impairments to individualized treatment is currently under evaluation in precision-guided trials. Such a translational approach may also be applicable across conditions and generalizable for the development of individualized neurostimulation targeting other behavioral deficits.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Oliver LD, Hawco C, Viviano JD, et al. From the Group to the Individual in Schizophrenia Spectrum Disorders: Biomarkers of Social Cognitive Impairments and Therapeutic Translation. Biol Psychiatry. 2021. PMID: 34799097. doi:10.1016/j.biopsych.2021.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。